
Keywords: هیپرپلازی گره لنفاوی آنژیوفولیکیکال; Castleman's disease; Multicentric Castleman's disease; Angiofollicular lymph node hyperplasia; Human immunodeficiency virus; Human herpes virus 8; Rituximab; Tocilizumab; SiltuximabEnfermedad de Castleman; Enfermedad de Castleman multicéntrica; Hiperplasi